Navigation Links
Genopole(R) is Organizing an Advanced Course on Stem Cells and Their Therapeutic Applications

From November 18th to 22nd, 2007, under the responsibility of Marc Peschanski, director of I-Stem(1), Genopole(R) is organizing an advanced course on stem cells and their therapeutic applications, aimed at exploring the latest advancements of research in this field, with input from 17 renowned specialists worldwide. Major topics to be covered include embryonic stem cells, mesenchymatic, hematopoetic, and organ stem cells and cloning.

Stem cells, whether embryonic or tissue-specific, are seen today as extremely useful tools showing therapeutic promising approach for many diseases.

Reproduced and differentiated on demand, they can enable the transfers of biological products needed for gene and cell therapy or represent flexible and powerful tools for screening molecules for predictive toxicology or therapeutic efficacy trials.

The body of gathered knowledge, which is already very large, can be even further extended, for example, to the hematopoetic system or epidermis. A certain number of key mechanisms remain unknown, particularly the two main characteristics of stem cells: on the one hand, their ability for self-renewal and, on the other, for differentiation.

This area of research has become a top priority at Genopole; next September 11th, Genopole, in cooperation with the AFM, Inserm and Universite d'Evry-Val-d'Essonne, will be inaugurating the I-Stem laboratory, directed by Marc Peschanski, one of the first researchers authorized to work on stem cells in France.

The audience will be limited to 40 participants. This course is intended for biologists already involved in stem cell research and wishing to reach a more detailed understanding of this area.


'"/>




Page: 1

Related medicine news :

1. Advanced STD programs required
2. Hope For Patients With Advanced Breast Cancer
3. HIV Vaccine Field Trials In Advanced Stage
4. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
5. Eddie Thompson Receives Advanced Cancer Treatment
6. PSA Can Predicts The Treatment Response In Advanced Prostate Cancer
7. Rapid Aging of Arteries In People With Advanced Heart Disease
8. Aricept Cleared for Advanced Alzheimers Treatment
9. Adding Radiation Therapy For Treatment of Advanced Prostate Cancer May Offer Benefit
10. New Pill for Patients With Advanced Prostate Cancer
11. Hormone Drug Type Makes Survival Difference in Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... presets. Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 for ... so many other applications. Users can pick and choose from hand-crafted trend-setting ...
(Date:2/17/2017)... ... 17, 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, ... and non-controlled substances plus the ability to manage orders on their desktop or ... accept electronic prescriptions, according to the Office of the National Coordinator of Health ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... 17, 2017 , ... PrideStaff, a national staffing organization, is ... Staffing Industry Analysts' 2017 "Staffing 100 North America" list. , Now in ... to the staffing industry over the last twelve months. Industry insiders and observers ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... planning assistance to families and business owners in the greater Fort Lauderdale metropolitan ... organization. , For more than 30 years, LifeNet 4 Families has provided ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. ... specialty pharmaceutical company, today announced that executive management will ... to be held February 22-23, 2017. Adrian Adams ... the Company at 1:35 p.m. local time on Wednesday, ... audio archive for the event may be accessed from ...
Breaking Medicine Technology: